Pamela Campbell, COT, CRP, and Grant Comer, M.D., M.S.
Conducting Clinical Trials During a Pandemic This year the Kellogg Clinical Research Center (KCRC) has more than 56 active clinical trials. These trials include gene therapies, new drugs and devices for age-related macular degeneration, glaucoma, dry eye and many other eye conditions. In addition to working on trials directly linked to vision and eye health, the KCRC supports other Michigan Medicine departments, providing expertise on the potential ophthalmic or visual side effects of treatments for non-vision related diseases, including cancer and genetic conditions. Many of our research coordinators even
Lindsay Godsey, M.S., COA, CCRP, Clinical Research Project Manager
volunteered and assisted Michigan Medicine colleagues with COVID-19-related clinical studies during the early
22
stages of the pandemic.
during this time, helping the KCRC remain state-of-the-art
for investigators and patients.
Due to state restrictions put in place in response to
the COVID-19 pandemic, non-urgent clinical trials were
suspended in the spring of 2020, similar to clinical care.
study activity has continued to grow, notes Grant Comer,
Facilities were remodeled and new equipment installed
MD., M.S., KCRC’s Medical Director.
As the coronavirus restrictions have been lifted, clinical
